Age, Biography and Wiki
David Ewing Duncan was born on 8 March, 1958 in Kansas City, Missouri, United States, is an American journalist. Discover David Ewing Duncan's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 66 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
66 years old |
Zodiac Sign |
Pisces |
Born |
8 March 1958 |
Birthday |
8 March |
Birthplace |
Kansas City, Missouri, United States |
Nationality |
United States
|
We recommend you to check the complete list of Famous People born on 8 March.
He is a member of famous journalist with the age 66 years old group.
David Ewing Duncan Height, Weight & Measurements
At 66 years old, David Ewing Duncan height not available right now. We will update David Ewing Duncan's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Not Available |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
David Ewing Duncan Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is David Ewing Duncan worth at the age of 66 years old? David Ewing Duncan’s income source is mostly from being a successful journalist. He is from United States. We have estimated David Ewing Duncan's net worth, money, salary, income, and assets.
Net Worth in 2024 |
$1 Million - $5 Million |
Salary in 2024 |
Under Review |
Net Worth in 2023 |
Pending |
Salary in 2023 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
journalist |
David Ewing Duncan Social Network
Timeline
David Ewing Duncan is an American journalist, author, and researcher on new discoveries and their implications for the life sciences.
He also writes about robots and artificial intelligence.
He is the author of 12 books and a journalist for Vanity Fair, Wired, Scientific American, The Atlantic, The New York Times, MIT Technology Review, National Geographic, and other publications.
He was a special correspondent and producer for Nightline, a commentator and producer for Morning Edition, and chief correspondent for Tech Nation on NPR.
He is the co-founder and curator of Arc Fusion, which holds events around the world for leaders and thinkers on the fusion of health, information technology biomedicine, and on the future of humans.
He is the creative director of Cure and recently was a health strategist-in-residence for IDEO.
Duncan was born in Kansas City, Missouri, and grew up in Lake Quivira, Kansas.
His father, Herbert Ewing Duncan, Jr., is an architect.
After cycling around the world and south to north through Africa in the 1980s, Duncan launched a career in journalism, writing for Life magazine and other publications, and serving as a commentator and contributor for NPR, mostly for Morning Edition.
From 1981-83, he led The World Bike for Hope, a 14,000-mile, 23-nation bicycle trek around the world that raised money for Project Hope and led to his first book, Pedaling the Ends of the Earth.
In 1986-87, he bicycled from Cape Town to Cairo in Africa, a voyage he chronicled for National Public Radio and in the book Cape to Cairo: An African Odyssey.
In 1993, he was appointed a special correspondent and producer for ABC Nightline, covering mostly healthcare and science.
He wrote four books, a biography of the conquistador Hernando de Soto (A Savage Quest in the Americas); a history of time (The Calendar), Masterminds: Genius, DNA, and the Quest to Rewrite Life, a book about the pioneers of genetics and synthetic biology, and an investigative book, Residents: The Perils and Promise of Educating Young Doctors, addressing how doctors are trained based on a story in Harper’s.
His mother, Patricia DuBose Duncan, was an artist, photographer, and environmental activist whose work helped lead to the establishment of the Tallgrass Prairie National Preserve in 1996.
He graduated from Vassar College, where he studied English literature and history.
In 1996, Nightline released a documentary, which tracked a 36-hour shift of a medical resident, based in part on his book.
He co-produced documentaries for the Discovery Channel and later was a correspondent-producer for NOVA’s ScienceNow!
In 1998, he was hired by producer Elliott Kastner to write a screenplay adapted from Duncan’s biography of Hernando de Soto, set in the future in outer space.
In 2001, Duncan was one of the first humans to be genetically sequenced, which was reported on in the magazine Wired. He reported the results in a series of articles for Discover, The Atlantic, MIT Technology Review, Conde Nast Portfolio, Wired, and other media.
In 2001, his documentary on the dotcom boom and bust (GoldRush.com) tracked the rise and fall of a start-up and the frenzy of this era in the Bay Area that aired on ABC Nightline.
From 2003 to 2008 he was co-founder, curator, and host of BioAgenda, a major gathering of leaders in the life sciences that was held most of those years in Palm Springs, California.
He is the founder and former director of The BioAgenda Institute for Life Science Policy, a San Francisco-based nonprofit think-tank that held summits, panels and discussions, and sponsored white papers on important issues in the life sciences between 2003 and 2008.
This led to the publication of the book Experimental Man in 2009.
He is currently at work on the Experimental Person Project, running new tests and updating his data to see what predictions were accurate and what the future might bring for his and everyone’s health.
In 2011, he gave a TEDx Brussels talk that led to a TED book on longevity titled When I’m 164: The Science of Radical Life Extension and What Happens if it Succeeds. He continues to cover the science and implications of anti-aging and longevity.
Duncan also covered the business, politics, and ethics of biotechnology for Fortune, Atlantic, and others, and covered the rise of high tech in Silicon Valley.
In 2011, he launched The Personalized Health Project, sponsored by The Ewing Marion Kauffman Foundation.
In 2012, he co-founded a genetic testing company based on his Experimental Man research that tested a person’s genetic sensitivity to environmental toxins like mercury.
In 2014, Duncan co-founded, curated, and hosted Arc Fusion events around the world.
In 2019, Duncan wrote Talking to Robots, a book of short stories that blended fiction and nonfiction and explored how technologies like AI and synthetic biology might turn out in the future.
He also teamed up with geneticist Craig Venter to write The Voyages of Sorcerer II, about Venter’s expeditions on his sailboat-research vessel to delve into the invisible world of microbes that connect all life on Earth.
Duncan writes for Vanity Fair, Wired, Scientific American, The New York Times, Technology Review, and the Daily Beast.
He is a former Contributing Editor to Wired, Discover, Condé Nast Portfolio and Technology Review. He also has written for The Atlantic, National Geographic, Fortune, Newsweek, Life, Outside, and Harper's, among many others.
Duncan was a longtime commentator for NPR’s Morning Edition and was Chief Correspondent on public radio's "Biotech Nation,” part of "Tech Nation,” broadcast weekly out of KQED in San Francisco.
In television, he was a special producer and correspondent for ABC Nightline, and a special producer for ABC’s 20/20.
He was a correspondent for NOVA’s Science Now, and a documentary co-producer for the Discovery Channel.
Duncan is a frequent speaker, and appears often in the media, including on the Today Show and NPR's All Things Considered, and Morning Edition.
Duncan was the founding director of the Center for Life Science Policy at the University of California, Berkeley.